Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture Changes-Reference-Cited by-同舟云学术

Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture Changes

Published:2016-06-27 Issue:3 Volume:358 Page:413-422
ISSN:1521-0103
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:Journal of Pharmacology and Experimental Therapeutics

Author:

Dong C.,Virtucio C.,Zemska O.,Baltazar G.,Zhou Y.,Baia D.,Jones-Iatauro S.,Sexton H.,Martin S.,Dee J.,Mak Y.,Meewan M.,Rock F.,Akama T.,Jarnagin K.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference71 articles.

1. Discovery and structure–activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis

2. Management of Difficult-to-Treat Atopic Dermatitis

3. The Majority of Epidermal T Cells in Psoriasis Vulgaris Lesions can Produce Type 1 Cytokines, Interferon-γ, Interleukin-2, and Tumor Necrosis Factor-α, Defining TC1 (Cytotoxic T Lymphocyte) and TH1 Effector Populations:1 a Type 1 Differentiation Bias is also Measured in Circulating Blood T Cells in Psoriatic Patients

4. Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis

5. TH1 and TH2 Lymphocyte Development and Regulation of TH Cell–Mediated Immune Responses of the Skin

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phosphodiesterase-4 inhibitors increase pigment cells proliferation and melanization in cultured melanocytes and within a 3D skin equivalent model;Journal of Investigative Dermatology;2024-09

2. Phosphodiesterase-4-Inhibitoren in der Dermatologie;Die Dermatologie;2024-08-30

3. Crisaborole combined with vitamin D demonstrates superior therapeutic efficacy over either monotherapy in mice with allergic contact dermatitis;Scientific Reports;2024-08-29

4. Long-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial;Journal of the American Academy of Dermatology;2024-08

5. The Psoriasis Treatment Pipeline;Dermatologic Clinics;2024-07